1. Introduction
===============

Quinazoline derivatives are an important class of nitrogen-containing heterocycles. They have attracted interest in the past because of their varied biological activities, such as anticonvulsant, antihypertensive, vasodilator, antiinflammatory, antibiosis, fibrinogen receptor antagonistic and nanomolar Hedgehog-antagonistic properties \[[@B1-molecules-18-05580],[@B2-molecules-18-05580],[@B3-molecules-18-05580],[@B4-molecules-18-05580],[@B5-molecules-18-05580],[@B6-molecules-18-05580],[@B7-molecules-18-05580],[@B8-molecules-18-05580]\]. Among the family of quinazolines, quinazoline (thio)ethers, including 4-arylthioquinazolines and 4-aryloxyquinazolines, have received considerable interest because of their potential pharmacological activity \[[@B9-molecules-18-05580],[@B10-molecules-18-05580],[@B11-molecules-18-05580],[@B12-molecules-18-05580],[@B13-molecules-18-05580],[@B14-molecules-18-05580],[@B15-molecules-18-05580],[@B16-molecules-18-05580]\].

Generally, 4-arylthioquinazolines and 4-aryloxyquinazolines are obtained through S~N~Ar substitution of electron-deficient 4-chloroquinazolines with the appropriate thiophenols or phenols in the presence of a base \[[@B9-molecules-18-05580],[@B10-molecules-18-05580],[@B11-molecules-18-05580],[@B12-molecules-18-05580],[@B13-molecules-18-05580],[@B14-molecules-18-05580],[@B15-molecules-18-05580],[@B16-molecules-18-05580],[@B17-molecules-18-05580],[@B18-molecules-18-05580],[@B19-molecules-18-05580]\]. The common method for preparation of 4-chloroquinazolines is the chlorination of corresponding quinazolin-4(3*H*)-ones. The chlorination reagents used include SOCl~2~, POCl~3~, PCl~5~ or their combinations, and the chlorination reactions are usually performed under harsh conditions. However, these chlorination reagents are not environmentally friendly, and some sensitive functional groups may be destroyed under the chlorination conditions. In addition, many 4-chloroquinazoline derivatives are moisture sensitive, thus special treatments are required for their purification and storage.

In order to avoid the use of chlorination reagents and an individual activation step, an *in situ* activation of quinazolin-4(3*H*)-ones is highly desirable. Phosphonium compounds, such as benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (BOP), have been developed to activate quinazolin-4(3*H*)-ones and successfully employed in the synthesis of 4-aminoquinazolines, 4-arylthioquinazolines and 4-aryloxyquinazolines using amine, thiophenol and phenol nucleophiles, respectively \[[@B20-molecules-18-05580],[@B21-molecules-18-05580]\]. However, BOP and other phosphonium reagents are expensive, moreover, utilization of BOP generates as an end product HMPA, a highly carcinogenic chemical.

As a part of our research program focused on quinazoline chemistry \[[@B22-molecules-18-05580],[@B23-molecules-18-05580]\], we have recently, reported that hexachlorocyclotriphosphazene (Cl~6~N~3~P~3~, HCCP) can be used as an inexpensive and readily available activating reagent in the direct amination of quinazolin-4(3*H*)-ones (**1**) \[[@B24-molecules-18-05580]\]. In the reaction, quinazolin-4(3*H*)-ones are activated *in situ* with HCCP to generate the highly reactive phosphonium intermediate **2**, then amines can nucleophilically attack **2** to form 4-aminoquinazolines. Thus, we speculated that other nucleophiles, such as thiophenol and phenol ones, might attack **2** to form the corresponding products. Herein, we report a HCCP-mediated, single-pot, facile synthesis of thioethers and ethers from quinazolin-4(3*H*)-ones in moderate to excellent yields ([Scheme 1](#molecules-18-05580-scheme1){ref-type="scheme"}).

![One-pot synthesis of quinazoline (thio)ethers from quinazolin-4(3*H*)-ones mediated by HCCP.](molecules-18-05580-g001){#molecules-18-05580-scheme1}

2. Results and Discussion
=========================

Initially, the reaction of quinazolin-4(3*H*)-one (**1a**) and thiophenol was investigated as the model reaction to establish the feasibility of the strategy and to optimize the reaction conditions. The effects of solvent, base, temperature and HCCP loading, *etc*., were evaluated for this model reaction, and the results are summarized in [Table 1](#molecules-18-05580-t001){ref-type="table"}.

molecules-18-05580-t001_Table 1

###### 

Optimization of reaction conditions ^a^. ![](molecules-18-05580-i055.jpg)

  Entry   Base         Solvent      Temperature (°C)   Yield (%) ^b^
  ------- ------------ ------------ ------------------ ---------------
  1       TEA          MeCN         45                 48
  2       K~2~CO~3~    MeCN         45                 32
  3       Cs~2~CO~3~   MeCN         45                 69
  4       DIPEA        MeCN         45                 81
  5       DIPEA        THF          45                 12
  6       DIPEA        DMF          45                 23
  7       DIPEA        CH~2~Cl~2~   45                 7
  8       DIPEA        MeCN         45                 76 ^c^
  9       DIPEA        MeCN         25                 68
  10      DIPEA        MeCN         65                 55
  11      DIPEA        MeCN         45                 79 ^d^
  12      DIPEA        MeCN         45                 71 ^e^
  13      DIPEA        MeCN         45                 81 ^f^
  14      DIPEA        MeCN         45                 70 ^g^

^a^ Conditions: **1a** (0.5 mmol), HCCP (1.1 equiv.), base (5.0 equiv.), solvent (5 mL), rt, activation time (1 h), then thiophenol (6.0 equiv.), 45 °C, 23 h; ^b^ Isolated yield; ^c^ HCCP (1.0 equiv.); ^d^ Thiophenol (5.0 equiv.); ^e^ Thiophenol (4.0 equiv.); ^f^ DIPEA (6.0 equiv.); ^g^ DIPEA (4.0 equiv.).

Compared with triethylamine (TEA), K~2~CO~3~ and Cs~2~CO~3~ (entries 1--3), diisopropylethylamine (DIPEA) was found to be the most effective in the model reaction of **1a** and thiophenol (entry 4). The results in [Table 1](#molecules-18-05580-t001){ref-type="table"} show that the solvent can greatly affect the reaction, and acetonitrile led to much better yield of product **3** than tetrahydrofuran, *N,N*-dimethylformamide or dichloromethane (entries 4--7). According to [Scheme 1](#molecules-18-05580-scheme1){ref-type="scheme"}, 1.0 equiv. HCCP loading was enough, but we found that increasing the HCCP loading from 1.0 to 1.1 equiv. resulted in 5% yield increases (entry 8 *versus* entry 4). After *in situ* activation of **1a** with HCCP at room temperature for 1 h, the S~N~Ar substitution of phosphonium intermediate **2a** (R^1^ = H) with thiophenol was performed at 45 °C. At both lower and higher temperature, the yield of **3** decreased (entries 9 and 10). Like the HCCP-mediated direct amination of quinazolin-4(3*H*)-ones with amines \[[@B24-molecules-18-05580]\], when the thiophenol nucleophile attacks **2a**, two competitive S~N~Ar substitutions were possible, either on the C--O bond or P--Cl bond. Thus, five to six equiv. of thiophenol and DIPEA were needed in this reaction. It was found variation of the amount of thiophenol or DPIEA from 6.0 equiv. to 5.0 equiv. did not significantly change the results (entry 4 *versus* entries 11 and 13), whereas upon decreasing the amount of thiophenol or DPIEA to 4.0 equiv., the yield of **3** was obviously decreased (entries 12 and 14). On the basis of these experimental data, the optimal reaction conditions were: 1.1 equiv. of HCCP, 5.0 equiv. of DIPEA, 5.0 equiv. of thiophenol, 45 °C of reaction temperature and acetonitrile as the reaction solvent, and these were employed in the following studies.

The results of HCCP-mediated direct formation of thioethers (4-arylthioquinazolines) from 1 and thiophenols are summarized in [Table 2](#molecules-18-05580-t002){ref-type="table"}. Different substituted thiophenols smoothly reacted with **1a** to afford the desired 4-arylthioquinazolines in moderate to excellent yields (entries 1--9). When *o*, *m*, and *p*-methoxythiophenols were used as the nucleophiles, *o*-methoxythiophenol gave the highest product yield, while *m*-methoxythiophenol showed the lowest reactivity (entries 4--6). It is noteworthy that chlorothiophenols, which usually exhibit lower nucleophilicity than methoxythiophenols, could conveniently undergo the transformation and gave excellent product yields in this HCCP-mediated direct formation of 4-arylthioquinazolines (entries 7 and 9). The reactions between thiophenol and a variety of substituted quinazolin-4(3*H*)-ones were also investigated. An array of substituted quinazolin-4(3*H*)-ones were suitable for this HCCP-mediated formation of thioethers and gave the desired 4-arylthioquinazolines in moderate to good yields (entries 1, 10--15). When 5-methylquinazolin-4(3*H*)-one (**1b**) and 5-chloroquinazolin-4(3*H*)-one (**1e**) were used as the substrates, activation time should be prolonged (entries 10 and 13).

molecules-18-05580-t002_Table 2

###### 

HCCP-mediated formation of quinazoline thioethers from quinazolin-4(3*H*)-ones ^a^. ![](molecules-18-05580-i056.jpg)

  Entry   Quinazolin-4(3*H*)-one             ArSH     Product                            Yield (%) ^b^                               
  ------- ---------------------------------- -------- ---------------------------------- ---------------------------------- -------- --------
  1       ![](molecules-18-05580-i001.jpg)   **1a**   ![](molecules-18-05580-i011.jpg)   ![](molecules-18-05580-i023.jpg)   **3**    79
  2       **1a**                                      ![](molecules-18-05580-i034.jpg)   ![](molecules-18-05580-i041.jpg)   **4**    64 ^c^
  3       **1a**                                      ![](molecules-18-05580-i042.jpg)   ![](molecules-18-05580-i046.jpg)   **5**    69
  4       **1a**                                      ![](molecules-18-05580-i044.jpg)   ![](molecules-18-05580-i045.jpg)   **6**    59
  5       **1a**                                      ![](molecules-18-05580-i002.jpg)   ![](molecules-18-05580-i003.jpg)   **7**    50
  6       **1a**                                      ![](molecules-18-05580-i004.jpg)   ![](molecules-18-05580-i005.jpg)   **8**    86
  7       **1a**                                      ![](molecules-18-05580-i006.jpg)   ![](molecules-18-05580-i036.jpg)   **9**    94
  8       **1a**                                      ![](molecules-18-05580-i057.jpg)   ![](molecules-18-05580-i007.jpg)   **10**   66
  9       **1a**                                      ![](molecules-18-05580-i008.jpg)   ![](molecules-18-05580-i009.jpg)   **11**   91
  10      ![](molecules-18-05580-i010.jpg)   **1b**   ![](molecules-18-05580-i012.jpg)   ![](molecules-18-05580-i013.jpg)   **12**   54 ^d^
  11      ![](molecules-18-05580-i014.jpg)   **1c**   ![](molecules-18-05580-i015.jpg)   ![](molecules-18-05580-i016.jpg)   **13**   60
  12      ![](molecules-18-05580-i017.jpg)   **1d**   ![](molecules-18-05580-i018.jpg)   ![](molecules-18-05580-i019.jpg)   **14**   64
  13      ![](molecules-18-05580-i020.jpg)   **1e**   ![](molecules-18-05580-i021.jpg)   ![](molecules-18-05580-i022.jpg)   **15**   51 ^d^
  14      ![](molecules-18-05580-i024.jpg)   **1f**   ![](molecules-18-05580-i025.jpg)   ![](molecules-18-05580-i026.jpg)   **16**   79
  15      ![](molecules-18-05580-i027.jpg)   **1g**   ![](molecules-18-05580-i028.jpg)   ![](molecules-18-05580-i029.jpg)   **17**   72

^a^*Reagents andConditions*: **1** (0.5 mmol), HCCP (1.1 equiv.), DIPEA (5.0 equiv.), MeCN (5 mL), rt, activation time (1 h), then thiophenols (5.0 equiv.), 45 °C, 23 h; ^b^ Isolated yield; ^c^*m*-CH~3~PhSH (6.0 equiv.); reaction time (48 h); ^d^ Activation time (20 h).

The method was further extended to the synthesis of 4-aryloxyquinazolines through the reaction of **1** and phenols under the same reaction conditions ([Table 3](#molecules-18-05580-t003){ref-type="table"}). Different phenols (phenol, *m*-methylphenol, *o*-chlorophenol and *p*-chlorophenol) could react with **1b** and afforded the corresponding products **18**--**21** in moderate to good yields (entry 1--5). There is no significant electronic effect of substituents for products. Substituted quinazolin-4(3*H*)-ones were also used as the substrates to react with phenol. 6-Chloroquinazolin-4(3*H*)-one (**1f**) and 7-chloroquinazolin-4(3*H*)-one (**1g**) gave products **14** and **15** in 70% yield (entries 6 and 7), whereas in the case of 5-methylquinazolin-4(3*H*)-one (**1b**), the product **12** was obtained in 54% yield (entry 5). Alcohols were also used as the nucleophiles in this reaction. Unfortunately, no desired 4-alkoxyquinazolines were formed. It might be due to that the nucleophilicity of alcohols was too weak to undego S~N~Ar substitution. Thus, sodium alkoxides were further utilized as the nucleophiles in this reaction to give the corresponding 4-alkoxyquinazolines ([Table 3](#molecules-18-05580-t003){ref-type="table"}). When **1a**, 8-methylquinazolin-4(3*H*)-one (**1d**) and **1g** reacted with sodium ethoxide for 3 h, the yields of products 4-ethoxyquinazolines were 54%, 64% and 67%, respectively (entries 8,10 and 11), while **1b** gave only 33% product yield (entry 9). 4-Propoxyquinazoline (**29**) could be obtained in 48% yield in the reaction between **1a** and sodium propoxide (entry 12).

molecules-18-05580-t003_Table 3

###### 

HCCP-mediated formation of quinazoline ethers from quinazolin-4(3*H*)-ones ^a^. ![](molecules-18-05580-i058.jpg)

  Entry   Quinazolin-4(3*H*)-one   ArOH or RONa                       Product                            Yield (%) ^b^   
  ------- ------------------------ ---------------------------------- ---------------------------------- --------------- --------
  1       **1a**                   ![](molecules-18-05580-i030.jpg)   ![](molecules-18-05580-i031.jpg)   **18**          75
  2       **1a**                   ![](molecules-18-05580-i032.jpg)   ![](molecules-18-05580-i033.jpg)   **19**          52
  3       **1a**                   ![](molecules-18-05580-i035.jpg)   ![](molecules-18-05580-i037.jpg)   **20**          73
  4       **1a**                   ![](molecules-18-05580-i038.jpg)   ![](molecules-18-05580-i039.jpg)   **21**          51
  5       **1b**                   ![](molecules-18-05580-i040.jpg)   ![](molecules-18-05580-i046.jpg)   **22**          53 ^c^
  6       **1f**                   ![](molecules-18-05580-i047.jpg)   ![](molecules-18-05580-i049.jpg)   **23**          70
  7       **1g**                   ![](molecules-18-05580-i048.jpg)   ![](molecules-18-05580-i059.jpg)   **24**          70
  8       **1a**                   CH~3~CH~2~ONa                      ![](molecules-18-05580-i050.jpg)   **25**          54
  9       **1b**                   CH~3~CH~2~ONa                      ![](molecules-18-05580-i051.jpg)   **26**          33 ^c^
  10      **1d**                   CH~3~CH~2~ONa                      ![](molecules-18-05580-i052.jpg)   **27**          67
  11      **1g**                   CH~3~CH~2~ONa                      ![](molecules-18-05580-i053.jpg)   **28**          64
  12      **1a**                   CH~3~CH~2~CH~2~ONa                 ![](molecules-18-05580-i054.jpg)   **29**          48

^a^ *Reagents and Conditions*: **1** (0.5 mmol), HCCP (1.1 equiv.), DIPEA (5.0 equiv.), MeCN (5 mL), rt, activation time (1 h), then phenols (5.0 equiv.), 45 °C, 23 h; or R^2^ONa (5.0 equiv.), 45 °C, 3 h; ^b^ Isolated yield; ^c^ Activation time (20 h).

3. Experimental
===============

3.1. General
------------

^1^H-NMR (500 MHz) and ^13^C-NMR (125 MHz) spectra were obtained on a Bruker Avance III spectrometer. CDCl~3~ and DMSO-*d*~6~ were used as the solvent with tetramethylsilane (TMS) as the internal standard. Low and high resolution mass spectra were recorded in the ESI mode on an Agilent 6210 LC/TOF mass spectrometer. Melting points were measured using XRL-1 melting point instrument and are uncorrected. Quinazolin-4(3*H*)-ones were synthesized from anthranilic acids and formamidine acetate, and their structures were confirmed by MS, ^1^H-NMR, and ^13^C-NMR. Other reagents were purchased from supplier and used without any further treatment.

3.2. General Procedure for HCCP-Mediated Formation of Thioethers and Ethers from Quinazolin-4(3H)-ones
------------------------------------------------------------------------------------------------------

Quinazolin-4(3*H*)-ones (**1**, 0.5 mmol), HCCP (171.2 mg, 0.55 mmol, 1.1 equiv.), DIPEA (323.8 mg, 2.5 mmol, 5 equiv.), and CH~3~CN (5 mL) were added to a nitrogen purged vial. The reaction mixture was stirred at room temperature for 1 h as activation time. Then nucleophile (2.5 mmol, 5 equiv. was added, and the reaction mixture was stirred at 45 °C for 23 h. The reaction mixture was partially concentrated under reduced pressure. The crude product was separated on a silica gel plate with ethyl acetate--hexane (1:10 or 1:5) as eluent. Then the area corresponding to the product was scraped off the TLC plate, and extracted with dichloromethane. The extract was concentrated to afford the corresponding products (**3**--**29**).

*4-(Phenylthio)quinazoline* (**3**). White solid (79% yield); mp 109--110 °C; ^1^H-NMR (DMSO-*d6*) δ 8.84 (s, 1H), 8.27 (d, *J* = 8.5 Hz, 1H), 8.07--8.04 (m, 1H), 8.00--7.99 (m, 1H), 7.83--7.79 (m, 1H), 7.68--7.66 (m, 2H), 7.56--7.54 (m, 3H); ^13^C-NMR (DMSO-*d6*) δ 170.3, 153.5, 147.8, 135.8, 134.6, 129.9, 129.6, 128.5, 128.4, 126.5, 123.6, 122.3; HRMS (ESI), *m/z*, 239.0644 \[MH^+^\], calcd for C~14~H~11~N~2~S, 239.0643.

*4-(m-Tolylthio)quinazoline* (**4**). White solid (64% yield); mp 58--61 °C; ^1^H-NMR (DMSO-*d6*) δ 8.83 (s, 1H), 8.25 (d, *J* = 8.0 Hz, 1H), 8.05--8.02 (m, 1H), 7.99--7.97 (m, 1H), 7.81--7.77 (m, 1H), 7.48--7.41 (m, 3H), 7.36--7.35 (m, 1H), 2.37 (s, 3H); ^13^C-NMR (DMSO-*d6*) δ 170.5, 153.5, 147.8, 139.0, 136.0, 134.6, 132.9, 130.6, 129.4, 128.5, 128.3, 126.2, 123.6, 122.4, 20.7; HRMS (ESI), *m/z*, 253.0795 \[MH^+^\], calcd for C~15~H~13~N~2~S, 253.0799.

*4-(p-Tolylthio)quinazoline* (**5**) White solid (69% yield); mp 104--105 °C; ^1^H-NMR (DMSO-*d6*) δ 8.81 (s, 1H), 8.19 (d, *J* = 8.0 Hz, 1H), 8.02--7.98 (m, 1H), 7.96--7.95 (m, 1H), 7.77--7.73 (m, 1H), 7.50--7.48 (m, 2H), 7.31 (d, *J* = 8.0 Hz, 2H), 2.38 (s, 3H); ^13^C-NMR (DMSO-*d6*) δ 170.6, 153.4, 147.7, 139.7, 135.7, 134.4, 130.1, 128.4, 128.2, 123.4, 122.9, 122.3, 20.8; HRMS (ESI), *m/z*, 253.0798 \[MH^+^\], calcd for C~15~H~13~N~2~S, 253.0799.

*4-(2-Methoxyphenylthio)quinazoline* (**6**). White solid (59% yield); mp 111--113 °C; ^1^H-NMR (DMSO-*d6*) δ 8.80 (s, 1H), 8.27 (d, *J* = 8.0 Hz, 1H), 8.04--8.01 (m, 1H), 7.98--7.96 (m, 1H), 7.80--7.76 (m, 1H), 7.60--7.54 (m, 2H), 7.20 (d, *J* = 8.0 Hz, 1H), 7.10--7.07 (m, 1H), 3.74 (s, 3H); ^13^C-NMR (DMSO-*d6*) δ 170.0, 160.0, 153.5, 147.8, 137.5, 134.4, 132.2, 128.4, 128.2, 123.7, 122.5, 121.2, 114.2, 112.3, 55.9; HRMS (ESI), *m/z*, 269.0747 \[MH^+^\], calcd for C~15~H~13~N~2~OS, 269.0749.

*4-(3-Methoxyphenylthio)quinazoline* (**7**). White solid (50% yield); mp 80--82 °C; ^1^H-NMR (DMSO-*d6*) δ 8.86 (s, 1H), 8.25 (d, *J* = 8.0 Hz, 1H), 8.06--8.03 (m, 1H), 8.00--7.98 (m, 1H), 7.81--7.78 (m, 1H), 7.47--7.44 (m, 1H), 7.24--7.22 (m, 2H), 7.14--7.11 (m, 1H), 3.80 (s, 3H); ^13^C-NMR (DMSO-*d6*) δ 170.3, 159.7, 153.5, 147.8, 134.6, 130.3, 128.5, 128.3, 127.8, 127.5, 123.5, 122.4, 120.9, 115.7, 55.3; HRMS (ESI), *m/z*, 269.0746 \[MH^+^\], calcd for C~15~H~13~N~2~OS, 269.0749.

*4-(4-Methoxyphenylthio)quinazoline* (**8**). White solid (86% yield); mp 125--128 °C; ^1^H-NMR (DMSO-*d6*) δ 8.82 (s, 1H), 8.24 (d, *J* = 8.0 Hz, 1H), 8.04--8.01 (m, 1H), 7.98--7.96 (m, 1H), 7.80--7.77 (m, 1H), 7.57--7.54 (m, 2H), 7.10--7.09 (m, 2H), 3.84 (s, 3H); ^13^C-NMR (DMSO-*d6*) δ 171.1, 160.7, 153.5, 147.7, 137.6, 134.6, 128.4, 128.3, 123.6, 122.3, 116.6, 115.3, 55.4; HRMS (ESI), *m/z*, 269.0739 \[MH^+^\], calcd for C~15~H~13~N~2~OS, 269.0749.

*4-(2-Chlorophenylthio)quinazoline* (**9**). White solid (94% yield); mp 124--126 °C; ^1^H-NMR (DMSO-*d6*) δ 8.85 (s, 1H), 8.29 (d, *J* = 8.0 Hz, 1H), 8.08--8.05 (m, 1H), 8.02--8.00 (m, 1H), 7.84--7.80 (m, 2H), 7.74--7.72 (m, 1H), 7.62--7.59 (m, 1H), 7.52--7.49 (m, 1H); ^13^C-NMR (DMSO-*d6*) δ 168.9, 153.4, 147.9, 138.8, 138.4, 134.7, 132.2, 130.3, 128.51, 128.47, 128.2, 125.9, 123.6, 122.3; HRMS (ESI), *m/z*, 273.0244 \[MH^+^\], calcd for C~14~H~10~ClN~2~S, 273.0253.

*4-(3-Chlorophenylthio)quinazoline* (**10**). White solid (66% yield); mp 125--126 °C; ^1^H-NMR (DMSO-*d6*) δ 8.86 (s, 1H), 8.23 (d, *J* = 8.0 Hz, 1H), 8.04--8.03 (m, 1H), 8.00--7.98 (m, 1H), 7.81--7.76 (m, 2H), 7.65--7.61 (m, 2H), 7.58--7.55 (m, 1H); ^13^C-NMR (DMSO-*d6*) δ 169.7, 153.4, 147.9, 135.0, 134.7, 134.4, 133.6, 131.1, 129.9, 128.8, 128.5, 128.4, 123.5, 122.3; HRMS (ESI), *m/z*, 273.0243 \[MH^+^\], calcd for C~14~H~10~ClN~2~S, 273.0253.

*4-(4-Chlorophenylthio)quinazoline* (**11**). White solid (91% yield); mp 133-134 °C; ^1^H-NMR (DMSO-*d6*) δ 8.85 (s, 1H), 8.24 (d, *J* = 8.0 Hz, 1H), 8.07--8.03 (m, 1H), 8.00--7.99 (m, 1H), 7.82--7.79 (m, 1H), 7.70--7.67 (m, 2H), 7.62--7.60 (m, 2H); ^13^C-NMR (DMSO-*d6*) δ 169.9, 153.4, 147.8, 137.5, 135.0, 134.7, 129.6, 128.5, 128.4, 125.5, 123.5, 122.3; HRMS (ESI), *m/z*, 273.0240 \[MH^+^\], calcd for C~14~H~10~ClN~2~S, 273.0253.

*5-Methyl-4-(phenylthio)quinazoline* (**12**). White solid (54% yield); mp 131--133 °C; ^1^H-NMR (DMSO-*d6*) δ 8.66 (s, 1H), 7.85--7.82 (m, 1H), 7.80--7.78 (m, 1H), 7.62--7.57 (m, 3H), 7.55--7.52 (m, 3H), 3.07 (s, 3H); ^13^C-NMR (DMSO-*d6*) δ 171.3, 152.2, 150.2, 135.9, 135.4, 133.4, 130.8, 129.7, 129.5, 128.2, 127.0, 123.4, 24.7; HRMS (ESI), *m/z*, 253.0790 \[MH^+^\], calcd for C~15~H~13~N~2~S, 253.0799.

*6-Methyl-4-(phenylthio)quinazoline* (**13**). White solid (60% yield); mp 100--102 °C; ^1^H-NMR (DMSO-*d6*) δ 8.83 (s, 1H), 8.00 (s, 1H), 7.89 (d, *J* = 8.5 Hz, 1H), 7.73 (d, *J* = 8.5 Hz, 1H), 7.67--7.65 (m, 2H), 7.52--7.51 (m, 3H), 2.62 (s, 3H); ^13^C-NMR (DMSO-*d6*) δ 170.4, 153.3, 146.9, 137.9, 136.0, 135.8, 129.7, 129.4, 128.6, 127.4, 123.3, 122.7, 21.8; HRMS (ESI), *m/z*, 253.0796 \[MH^+^\], calcd for C~15~H~13~N~2~S, 253.0799.

*8-Methyl-4-(phenylthio)quinazoline* (**14**). White solid (64% yield); mp 98--100 °C; ^1^H-NMR (DMSO-*d6*) δ 8.84 (s, 1H), 8.04 (d, *J* = 8.0 Hz, 1H), 7.85 (d, *J* = 7.0 Hz, 1H), 7.65--7.62 (m, 3H), 7.54-7.53 (m, 3H), 2.66 (s, 3H); ^13^C-NMR (DMSO-*d6*) δ 170.3, 152.6, 146.8, 136.7, 135.7, 134.2, 129.7, 129.5, 127.7, 126.8, 122.2, 121.1, 17.0; HRMS (ESI), *m/z*, 253.0789 \[MH^+^\], calcd for C~15~H~13~N~2~S, 253.0799.

*5-Chloro-4-(phenylthio)quinazoline* (**15**). White solid (51% yield); mp 133--134 °C; ^1^H-NMR (CDCl~3~) δ 8.73 (s, 1H), 7.91--7.89 (m, 1H), 7.74--7.68 (m, 2H), 7.60--7.58 (m, 2H), 7.51--7.50 (m, 3H); ^13^C-NMR (CDCl~3~) δ 172.5, 153.2, 151.3, 135.9, 132.7, 130.6, 129.9, 129.7, 129.4, 129.3, 128.5, 122.6; HRMS (ESI), *m/z*, 273.0244 \[MH^+^\], calcd for C~14~H~10~ClN~2~S, 273.0253.

*6-Chloro-4-(phenylthio)quinazoline* (**16**). White solid (79% yield); mp 103--105 °C; ^1^H-NMR (CDCl~3~) δ 8.86 (s, 1H), 8.22 (d, *J* = 2.0 Hz, 1H), 7.93 (d, *J* = 9.0 Hz, 1H), 7.83-7.81 (m, 1H), 7.66--7.64 (m, 2H), 7.53--7.51 (m, 3H); ^13^C-NMR (CDCl~3~) δ 170.7, 154.0, 146.9, 135.8, 134.8, 133.3, 130.5, 130.0, 129.5, 126.7, 123.8, 122.9; HRMS (ESI), *m/z*, 273.0241 \[MH^+^\], calcd for C~14~H~10~ClN~2~S, 273.0253.

*7-Chloro-4-(phenylthio)quinazoline* (**17**). White solid (72% yield); mp 142--143 °C; ^1^H-NMR (DMSO-*d6*) δ 8.85 (s, 1H), 8.29 (d, *J* = 9.0 Hz, 1H), 8.07 (d, *J* = 2.0 Hz, 1H), 7.83--7.81 (m, 1H), 7.67--7.66 (m, 2H), 7.57--7.55 (m, 3H); ^13^C-NMR (DMSO-*d6*) δ 170.7, 154.5, 148.6, 139.2, 135.7, 130.0, 129.6, 128.9, 127.3, 126.1, 125.7, 121.0; HRMS (ESI), *m/z*, 273.0255 \[MH^+^\], calcd for C~14~H~10~ClN~2~S, 273.0253.

*4-Phenoxyquinazoline* (**18**). White solid (75% yield); mp 123--125 °C; ^1^H-NMR (CDCl~3~) δ 8.80 (s, 1H), 8.42--8.40 (m, 1H), 8.03 (d, *J* = 8.5 Hz, 1H), 7.96--7.94 (m, 1H), 7.69 (t, *J* =1.0 Hz, 1H), 7.54--7.50 (m, 2H), 7.37--7.35 (m, 1H), 7.30--7.28 (m, 2H); ^13^C-NMR (CDCl~3~) δ 167.0, 154.4, 152.4, 151.7, 134.2, 129.8, 128.0, 127.6, 126.1, 123.7, 121.9, 116.5; HRMS (ESI), *m/z*, 223.0868 \[MH^+^\], calcd for C~14~H~11~N~2~O, 223.0871.

*4-(m-Tolyloxy)quinazoline* (**19**). White solid (52% yield); mp 100--101 °C; ^1^H-NMR (CDCl~3~) δ 8.81 (s, 1H), 8.41--8.39 (m, 1H), 8.03 (d, *J* = 8.5 Hz, 1H), 7.95--7.92 (m, 1H), 7.70--7.67 (m, 1H), 7.41--7.38 (d, *J* = 7.5 Hz, 1H), 7.17--7.08 (m, 3H), 2.44 (s, 3H); ^13^C-NMR (CDCl~3~) δ 167.1, 154.4, 152.3, 151.6, 140.1, 134.1, 129.5, 127.9, 127.6, 126.9, 123.7, 122.4, 118.8, 116.5, 21.4; HRMS (ESI), *m/z*, 237.1025 \[MH^+^\], calcd for C~15~H~13~N~2~O, 237.1028.

*4-(2-Chlorophenoxy)quinazoline* (**20**). White solid (73% yield); mp 118--119 °C; ^1^H-NMR (CDCl~3~) δ 8.78 (s, 1H), 8.46--8.45 (m, 1H), 8.05 (d, *J* = 8.5 Hz, 1H), 7.98--7.96 (m, 1H), 7.74--7.72 (m, 1H), 7.57--7.56 (m, 1H), 7.43--7.41 (m, 1H), 7.38--7.36 (m, 1H), 7.34--7.32 (m, 1H); ^13^C-NMR (CDCl~3~) δ 166.2, 154.1, 151.9, 148.6, 134.3, 130.7, 128.1, 128.0, 127.8, 127.31, 127.26, 124.1, 123.7, 116.1; HRMS (ESI), *m/z*, 257.0479 \[MH^+^\], calcd for C~14~H~10~ClN~2~O, 257.0482.

*4-(4-Chlorophenoxy)quinazoline* (**21**). White solid (51% yield); mp 105--108 °C; ^1^H-NMR (CDCl~3~) δ 8.79 (s, H), 8.39 (d, *J* = 8.0 Hz, 1H), 8.04 (d, *J* = 8.5 Hz, 1H), 7.97--7.94 (m, 1H), 7.72--7.69 (m, 1H), 7.49--7.46 (m, 2H), 7.28--7.23 (m, 2H); ^13^C-NMR (CDCl~3~) δ 116.8, 154.1, 151.8, 150.9, 134.3, 131.5, 129.9, 128.0, 127.8, 123.5, 123.3, 116.3; HRMS (ESI), *m/z*, 257.0469 \[MH^+^\], calcd for C~14~H~10~ClN~2~O, 257.0482.

*5-Methyl-4-phenoxyquinazoline* (**22**). White solid (53% yield); mp 73--75 °C; ^1^H-NMR (CDCl~3~) δ 8.70 (s, 1H), 7.86 (d, *J* = 8.5 Hz, 1H), 7.77 (t, *J* = 7.5 Hz, 1H), 7.53--7.50 (m, 2H), 7.45 (d, *J* = 7.5 Hz, 1H), 7.36--7.33 (m, 1H), 7.28--7.25 (m, 2H), 3.00 (s, 3H); ^13^C-NMR (CDCl~3~) δ 168.0, 153.7, 153.4, 152.3, 136.7, 133.4, 129.9, 129.8, 126.1, 125.9, 122.0, 116.3, 24.1; HRMS (ESI), *m/z*, 237.1021 \[MH^+^\], calcd for C~15~H~13~N~2~O, 237.1028.

*6-Chloro-4-phenoxyquinazoline* (**23**). White solid (70% yield); mp 94--97 °C; ^1^H-NMR (CDCl~3~) δ 8.77 (s, 1H), 8.37 (d, *J* = 2.0 Hz, 1H), 7.96 (d, *J* = 9.0 Hz, 1H), 7.86--7.83 (m, 1H), 7.52--7.49 (m, 2H), 7.36--7.33 (m, 1H), 7.29--7.27 (m, 2H); ^13^C-NMR (CDCl~3~) δ 166.1, 154.4, 152.1, 150.1, 134.9, 133.2, 129.8, 129.6, 126.2, 122.7, 121.7, 117.1; HRMS (ESI), *m/z*, 257.0471 \[MH^+^\], calcd for C~14~H~10~ClN~2~O, 257.0482.

*7-Chloro-4-phenoxyquinazoline* (**24**). White solid (70% yield); mp 190--192 °C; ^1^H-NMR (CDCl~3~) δ 8.78 (s, 1H), 8.35 (d, *J* = 8.5 Hz, 1H), 8.03 (d, *J* = 2.0 Hz, 1H), 7.65--7.63 (m, 1H), 7.53--7.50 (m, 2H), 7.36 (t, *J* = 7.5 Hz, 1H), 7.29--7.27 ppm (m, 2H); ^13^C-NMR (CDCl~3~) δ 166.9, 155.5, 152.4, 152.2, 140.5, 129.8, 128.7, 127.2, 126.2, 125.2, 121.8, 114.9; HRMS (ESI), *m/z*, 257.0471 \[MH^+^\], calcd for C~14~H~10~ClN~2~O, 257.0482.

*4-Ethoxyquinazoline* (**25**). White solid (54% yield); mp 31--33 °C; ^1^H-NMR (CDCl~3~) δ 8.80 (s, 1H), 8.19--8.18 (m, 1H), 7.93 (d, *J* = 8.0 Hz, 1H), 7.84--7.81 (m, 1H), 7.58--7.54 (m, 1H), 4.64 (q, *J* = 7.0 Hz, 2H), 1.53 (t, *J* = 7.0 Hz, 3H); ^13^C-NMR (CDCl~3~) δ 166.7, 154.5, 150.9, 133.4, 127.7, 126.9, 123.6, 116.8, 63.1, 14.4; HRMS (ESI), *m/z*, 175.0873 \[MH^+^\], calcd for C~10~H~11~N~2~O, 175.0871.

*4-Ethoxy-5-methylquinazoline* (**26**). White solid (33% yield); mp 66--69 °C; ^1^H-NMR (CDCl~3~) δ 8.72 (s, 1H), 7.77 (d, *J* = 8.5 Hz, 1H), 7.67 (t, *J* = 7.5 Hz, 1H), 7.33 (d, *J* = 7.5 Hz, 1H), 4.61 (q, *J* = 7.0 Hz, 2H), 2.86 (s, 3H), 1.54 (t, *J* = 7.0 Hz, 3H); ^13^C-NMR (CDCl~3~) δ 167.8, 153.8, 152.6, 136.9, 132.7, 129.3, 125.8, 116.4, 63.1, 24.0, 14.4; HRMS (ESI), *m/z*, 189.1034 \[MH^+^\], calcd for C~11~H~13~N~2~O, 189.1028.

*4-Ethoxy-8-methylquinazoline* (**27**). White solid (67% yield); mp 31--32 °C; ^1^H-NMR (CDCl~3~) δ 8.84 (s, 1H), 8.04--8.02 (m, 1H), 7.66 (d, *J* = 7.5 Hz, 1H), 7.44 (t, *J* = 8.0 Hz, 1H), 4.63 (q, *J* = 7.0 Hz, 2H), 2.73 (s, 3H), 1.52 (t, *J* = 7.0 Hz, 3H); ^13^C-NMR (CDCl~3~) δ 166.9, 153.4, 150.0, 135.9, 133.5, 126.4, 121.2, 116.6, 62.9, 17.6, 14.3; HRMS (ESI), *m/z*, 189.1023 \[MH^+^\], calcd for C~11~H~13~N~2~O, 189.1028.

*7-Chloro-4-ethoxyquinazoline* (**28**). White solid (64% yield); mp 87--88 °C; ^1^H-NMR (CDCl~3~) δ 8.76 (s, 1H), 8.08 (d, *J* = 9.0 Hz, 1H), 7.90 (d, *J* = 1.5 Hz, 1H), 7.49--7.47 (m, 1H), 4.62 (q, *J* = 7.0 Hz, 2H), 1.51 (t, *J* = 7.0 Hz, 3H); ^13^C-NMR (CDCl~3~) δ 166.6, 155.5, 151.6, 139.6, 127.8, 126.9, 125.0, 115.0, 63.3, 14.3; HRMS (ESI), *m/z*, 209.0479 \[MH^+^\], calcd for C~10~H~10~ClN~2~O, 209.0482.

*4-Propoxyquinazoline* (**29**). White solid (48% yield); mp 190--192 °C; ^1^H-NMR (CDCl~3~) δ 8.79 (s, 1H), 8.19--8.17 (m, 1H), 7.92 (d, *J* = 8.5 Hz, 1H), 7.83--7.80 (m, 1H), 7.57--7.53 (m, 1H), 4.52 (t, *J* = 6.5 Hz, 2H), 1.95--1.91 (m, 2H), 1.10 (t, *J* = 7.5 Hz, 3H); ^13^C-NMR (CDCl~3~) δ 166.8, 154.4, 150.9, 133.4, 127.6, 126.9, 123.5, 116.7, 68.7, 22.1, 10.5; HRMS (ESI), *m/z*, 189.1023 \[MH^+^\], calcd for C~11~H~13~N~2~O, 189.1028.

4. Conclusions
==============

In summary, we have successfully developed an HCCP-mediated direct formation of thioethers (4-arylthioquinazolines) from quinazolin-4(3*H*)-ones and thiophenols in moderate to excellent yields. This method has also been utilized to prepare quinazoline ethers, including 4-aryloxyquinazolines and 4-alkoxyquinazolines, using phenols and sodium alkoxides as the nucleophiles. This direct formation of quinazoline (thio)ethers is mild, convenient, and suitable for a wide range of less expensive nucleophiles. This methodology would facilitate the syntheses of 4-arylthioquinazoline and 4-aryloxyquinazoline derivatives in medicinal chemistry.
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